drugset / Trial / NCT00903383

Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate

NCT00903383

Phase 2 Completed 208 enrolled Lexicon Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate the safety, tolerability, and effectiveness of LX3305 versus a placebo control in subjects with active rheumatoid arthritis on stable methotrexate therapy.

Timeline

Start
2009-07
Primary completion
2010-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject LX3305 Small molecule Oral

Indications